GlassScriptPhysician profile
Laurent Logan
NPI 1689166530
$4,313.70
in general payments reported to CMS, 2019-2025
10 companies · $4,231 in 2025
The $4,231 reported for 2025 was more than what 83% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $82.49 · 2025: $4,231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,139 · Travel and Lodging: $2,092.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,138.83 |
| Travel and Lodging | $2,092.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Balt USA, LLC | $2,135.87 | 2025 | Optima Coil System, Prestige Coil System, Carrier Delivery Catheter |
| Medtronic, INC. | $777.46 | 2025 | Pipeline, Linq II |
| Penumbra, INC. | $516.14 | 2025 | Red 72 |
| Inspiremd LTD | $179.96 | 2025 | Cguard Prime Carotid Stent System |
| Route 92 Medical, INC. | $160.00 | 2025 | |
| Cardiva Medical, INC. | $140.78 | 2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Stryker Corporation | $137.68 | 2025 | Surpass Evolve |
| Alexion Pharmaceuticals, INC. | $124.99 | 2025 | Ultomiris |
| E.R. Squibb & Sons, L.L.C. | $82.49 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.33 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurent Logan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.